nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—epilepsy syndrome—migraine	0.264	1	CtDrD
Zonisamide—Decreased Central Nervous System Disorganized Electrical Activity—Valproic Acid—migraine	0.129	0.392	CiPCiCtD
Zonisamide—Decreased Central Nervous System Disorganized Electrical Activity—Gabapentin—migraine	0.129	0.392	CiPCiCtD
Zonisamide—SCN1A—migraine	0.0818	0.531	CbGaD
Zonisamide—SCN2A—migraine	0.0721	0.469	CbGaD
Zonisamide—Decreased Central Nervous System Disorganized Electrical Activity—Topiramate—migraine	0.0707	0.215	CiPCiCtD
Zonisamide—CACNA1I—Verapamil—migraine	0.0202	0.128	CbGbCtD
Zonisamide—CACNA1G—Verapamil—migraine	0.0152	0.0959	CbGbCtD
Zonisamide—CACNA1H—Verapamil—migraine	0.0123	0.0777	CbGbCtD
Zonisamide—CA6—Topiramate—migraine	0.0108	0.0682	CbGbCtD
Zonisamide—CA5A—Topiramate—migraine	0.0108	0.0682	CbGbCtD
Zonisamide—CA7—Topiramate—migraine	0.00942	0.0595	CbGbCtD
Zonisamide—CA5B—Topiramate—migraine	0.00942	0.0595	CbGbCtD
Zonisamide—CA12—Topiramate—migraine	0.00809	0.051	CbGbCtD
Zonisamide—CA9—Topiramate—migraine	0.00809	0.051	CbGbCtD
Zonisamide—SCN1A—Topiramate—migraine	0.00809	0.051	CbGbCtD
Zonisamide—CA1—Topiramate—migraine	0.00757	0.0477	CbGbCtD
Zonisamide—CA4—Topiramate—migraine	0.00711	0.0449	CbGbCtD
Zonisamide—CA2—Topiramate—migraine	0.00654	0.0413	CbGbCtD
Zonisamide—SCN5A—Topiramate—migraine	0.00553	0.0349	CbGbCtD
Zonisamide—SCN5A—Verapamil—migraine	0.00534	0.0337	CbGbCtD
Zonisamide—CYP2C19—Timolol—migraine	0.00219	0.0138	CbGbCtD
Zonisamide—CA5B—cervicothoracic ganglion—migraine	0.0021	0.0921	CbGeAlD
Zonisamide—CYP2C19—Propranolol—migraine	0.00195	0.0123	CbGbCtD
Zonisamide—CYP2C19—Amitriptyline—migraine	0.00169	0.0107	CbGbCtD
Zonisamide—CYP2C19—Valproic Acid—migraine	0.00154	0.00971	CbGbCtD
Zonisamide—CYP2C19—Topiramate—migraine	0.00139	0.00876	CbGbCtD
Zonisamide—SCN1B—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00137	0.0483	CbGpPWpGaD
Zonisamide—SCN2B—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00137	0.0483	CbGpPWpGaD
Zonisamide—CYP2C19—Verapamil—migraine	0.00134	0.00846	CbGbCtD
Zonisamide—SCN4B—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00125	0.0441	CbGpPWpGaD
Zonisamide—SCN1B—Interaction between L1 and Ankyrins—SCN2A—migraine	0.00116	0.041	CbGpPWpGaD
Zonisamide—SCN2B—Interaction between L1 and Ankyrins—SCN2A—migraine	0.00116	0.041	CbGpPWpGaD
Zonisamide—SCN3B—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00116	0.041	CbGpPWpGaD
Zonisamide—SCN3A—spinal nerve—migraine	0.00107	0.047	CbGeAlD
Zonisamide—SCN4B—Interaction between L1 and Ankyrins—SCN2A—migraine	0.00106	0.0375	CbGpPWpGaD
Zonisamide—SCN3B—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000988	0.0349	CbGpPWpGaD
Zonisamide—CYP3A4—Propranolol—migraine	0.000944	0.00596	CbGbCtD
Zonisamide—CYP3A4—Amitriptyline—migraine	0.000817	0.00515	CbGbCtD
Zonisamide—CYP3A4—Valproic Acid—migraine	0.000744	0.0047	CbGbCtD
Zonisamide—CYP3A4—Topiramate—migraine	0.000672	0.00424	CbGbCtD
Zonisamide—CA13—nerve—migraine	0.000652	0.0286	CbGeAlD
Zonisamide—CYP3A4—Verapamil—migraine	0.000648	0.00409	CbGbCtD
Zonisamide—CA8—blood vessel—migraine	0.000598	0.0263	CbGeAlD
Zonisamide—SCN11A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.000595	0.021	CbGpPWpGaD
Zonisamide—SCN11A—peripheral nervous system—migraine	0.000572	0.0251	CbGeAlD
Zonisamide—SCN2B—L1CAM interactions—SCN1A—migraine	0.000524	0.0185	CbGpPWpGaD
Zonisamide—SCN1B—L1CAM interactions—SCN1A—migraine	0.000524	0.0185	CbGpPWpGaD
Zonisamide—SCN11A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000506	0.0179	CbGpPWpGaD
Zonisamide—SCN4B—L1CAM interactions—SCN1A—migraine	0.000479	0.0169	CbGpPWpGaD
Zonisamide—SCN11A—nerve—migraine	0.000446	0.0196	CbGeAlD
Zonisamide—SCN3B—L1CAM interactions—SCN1A—migraine	0.000446	0.0158	CbGpPWpGaD
Zonisamide—SCN2B—L1CAM interactions—SCN2A—migraine	0.000446	0.0158	CbGpPWpGaD
Zonisamide—SCN1B—L1CAM interactions—SCN2A—migraine	0.000446	0.0158	CbGpPWpGaD
Zonisamide—SCN9A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00044	0.0155	CbGpPWpGaD
Zonisamide—SCN2B—trigeminal ganglion—migraine	0.000435	0.0191	CbGeAlD
Zonisamide—MAOA—locus ceruleus—migraine	0.000434	0.0191	CbGeAlD
Zonisamide—SCN3A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.000421	0.0149	CbGpPWpGaD
Zonisamide—SCN4B—L1CAM interactions—SCN2A—migraine	0.000408	0.0144	CbGpPWpGaD
Zonisamide—SCN2A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.000404	0.0143	CbGpPWpGaD
Zonisamide—SCN4A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.000404	0.0143	CbGpPWpGaD
Zonisamide—SCN3B—L1CAM interactions—SCN2A—migraine	0.000379	0.0134	CbGpPWpGaD
Zonisamide—CA10—trigeminal ganglion—migraine	0.000377	0.0166	CbGeAlD
Zonisamide—SCN9A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000374	0.0132	CbGpPWpGaD
Zonisamide—SCN3B—trigeminal ganglion—migraine	0.000363	0.0159	CbGeAlD
Zonisamide—SCN3A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000358	0.0126	CbGpPWpGaD
Zonisamide—SCN4A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000344	0.0121	CbGpPWpGaD
Zonisamide—CA10—brainstem—migraine	0.000334	0.0147	CbGeAlD
Zonisamide—SCN1A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000331	0.0117	CbGpPWpGaD
Zonisamide—CA8—brainstem—migraine	0.000327	0.0144	CbGeAlD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000325	0.0115	CbGpPWpGaD
Zonisamide—SCN2B—cardiovascular system—migraine	0.000314	0.0138	CbGeAlD
Zonisamide—SCN4B—trigeminal ganglion—migraine	0.000308	0.0136	CbGeAlD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000302	0.0107	CbGpPWpGaD
Zonisamide—SCN1B—cardiovascular system—migraine	0.000284	0.0125	CbGeAlD
Zonisamide—CA13—brainstem—migraine	0.00028	0.0123	CbGeAlD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—HTR3A—migraine	0.000276	0.00977	CbGpPWpGaD
Zonisamide—SCN5A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.000274	0.00968	CbGpPWpGaD
Zonisamide—CA8—cardiovascular system—migraine	0.000267	0.0117	CbGeAlD
Zonisamide—CA11—trigeminal ganglion—migraine	0.000266	0.0117	CbGeAlD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—HTR3A—migraine	0.000257	0.00908	CbGpPWpGaD
Zonisamide—CA11—brainstem—migraine	0.000235	0.0103	CbGeAlD
Zonisamide—SCN5A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000233	0.00823	CbGpPWpGaD
Zonisamide—SCN11A—L1CAM interactions—SCN1A—migraine	0.000228	0.00806	CbGpPWpGaD
Zonisamide—SCN11A—trigeminal ganglion—migraine	0.000216	0.00951	CbGeAlD
Zonisamide—SCN2B—head—migraine	0.000213	0.00934	CbGeAlD
Zonisamide—SCN2B—nervous system—migraine	0.000202	0.00885	CbGeAlD
Zonisamide—SCN1B—Axon guidance—SCN1A—migraine	0.000198	0.007	CbGpPWpGaD
Zonisamide—SCN2B—Axon guidance—SCN1A—migraine	0.000198	0.007	CbGpPWpGaD
Zonisamide—SCN11A—L1CAM interactions—SCN2A—migraine	0.000194	0.00686	CbGpPWpGaD
Zonisamide—SCN2B—central nervous system—migraine	0.000194	0.00852	CbGeAlD
Zonisamide—SCN1B—head—migraine	0.000192	0.00845	CbGeAlD
Zonisamide—SCN2B—cerebellum—migraine	0.00019	0.00833	CbGeAlD
Zonisamide—CA1—nerve—migraine	0.000187	0.00823	CbGeAlD
Zonisamide—CA10—head—migraine	0.000184	0.0081	CbGeAlD
Zonisamide—SCN1B—nervous system—migraine	0.000182	0.00801	CbGeAlD
Zonisamide—SCN4B—Axon guidance—SCN1A—migraine	0.000181	0.0064	CbGpPWpGaD
Zonisamide—CA8—head—migraine	0.000181	0.00794	CbGeAlD
Zonisamide—SCN3B—head—migraine	0.000177	0.00779	CbGeAlD
Zonisamide—SCN1B—central nervous system—migraine	0.000175	0.00771	CbGeAlD
Zonisamide—CA10—nervous system—migraine	0.000175	0.00768	CbGeAlD
Zonisamide—SCN1B—cerebellum—migraine	0.000172	0.00753	CbGeAlD
Zonisamide—CA8—nervous system—migraine	0.000171	0.00753	CbGeAlD
Zonisamide—SCN9A—L1CAM interactions—SCN1A—migraine	0.000169	0.00596	CbGpPWpGaD
Zonisamide—SCN1B—Axon guidance—SCN2A—migraine	0.000168	0.00595	CbGpPWpGaD
Zonisamide—SCN2B—Axon guidance—SCN2A—migraine	0.000168	0.00595	CbGpPWpGaD
Zonisamide—SCN3B—Axon guidance—SCN1A—migraine	0.000168	0.00595	CbGpPWpGaD
Zonisamide—CA10—central nervous system—migraine	0.000168	0.00739	CbGeAlD
Zonisamide—SCN3B—nervous system—migraine	0.000168	0.00739	CbGeAlD
Zonisamide—MAOA—Serotonin Transporter Activity—SLC6A4—migraine	0.000166	0.00587	CbGpPWpGaD
Zonisamide—CA8—central nervous system—migraine	0.000165	0.00725	CbGeAlD
Zonisamide—CA10—cerebellum—migraine	0.000164	0.00722	CbGeAlD
Zonisamide—SCN3B—central nervous system—migraine	0.000162	0.00711	CbGeAlD
Zonisamide—SCN3A—L1CAM interactions—SCN1A—migraine	0.000161	0.0057	CbGpPWpGaD
Zonisamide—CA8—cerebellum—migraine	0.000161	0.00708	CbGeAlD
Zonisamide—SCN3B—cerebellum—migraine	0.000158	0.00695	CbGeAlD
Zonisamide—SCN4A—L1CAM interactions—SCN1A—migraine	0.000155	0.00548	CbGpPWpGaD
Zonisamide—SCN2A—L1CAM interactions—SCN1A—migraine	0.000155	0.00548	CbGpPWpGaD
Zonisamide—CA13—head—migraine	0.000155	0.0068	CbGeAlD
Zonisamide—SCN4B—Axon guidance—SCN2A—migraine	0.000154	0.00544	CbGpPWpGaD
Zonisamide—SCN2B—brain—migraine	0.000154	0.00677	CbGeAlD
Zonisamide—MAOB—nerve—migraine	0.000152	0.00668	CbGeAlD
Zonisamide—SCN4B—head—migraine	0.000151	0.00663	CbGeAlD
Zonisamide—CA13—nervous system—migraine	0.000147	0.00644	CbGeAlD
Zonisamide—CA4—nerve—migraine	0.000146	0.00643	CbGeAlD
Zonisamide—SCN9A—trigeminal ganglion—migraine	0.000144	0.00633	CbGeAlD
Zonisamide—SCN9A—L1CAM interactions—SCN2A—migraine	0.000144	0.00507	CbGpPWpGaD
Zonisamide—SCN3B—Axon guidance—SCN2A—migraine	0.000143	0.00506	CbGpPWpGaD
Zonisamide—SCN4B—nervous system—migraine	0.000143	0.00628	CbGeAlD
Zonisamide—SCN1B—Developmental Biology—SCN1A—migraine	0.000141	0.005	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—SCN1A—migraine	0.000141	0.005	CbGpPWpGaD
Zonisamide—CA13—central nervous system—migraine	0.000141	0.0062	CbGeAlD
Zonisamide—SCN1B—brain—migraine	0.000139	0.00612	CbGeAlD
Zonisamide—CA13—cerebellum—migraine	0.000138	0.00606	CbGeAlD
Zonisamide—SCN4B—central nervous system—migraine	0.000138	0.00605	CbGeAlD
Zonisamide—SCN3A—L1CAM interactions—SCN2A—migraine	0.000137	0.00485	CbGpPWpGaD
Zonisamide—SCN4B—cerebellum—migraine	0.000135	0.00591	CbGeAlD
Zonisamide—CA10—brain—migraine	0.000134	0.00587	CbGeAlD
Zonisamide—SCN4A—L1CAM interactions—SCN2A—migraine	0.000132	0.00466	CbGpPWpGaD
Zonisamide—CACNA1I—cerebellum—migraine	0.000131	0.00578	CbGeAlD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—HTR1A—migraine	0.000131	0.00464	CbGpPWpGaD
Zonisamide—CA8—brain—migraine	0.000131	0.00575	CbGeAlD
Zonisamide—CA11—head—migraine	0.00013	0.0057	CbGeAlD
Zonisamide—MAOA—nerve—migraine	0.00013	0.0057	CbGeAlD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—TAC1—migraine	0.000129	0.00457	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—SCN1A—migraine	0.000129	0.00457	CbGpPWpGaD
Zonisamide—SCN3B—brain—migraine	0.000129	0.00565	CbGeAlD
Zonisamide—SCN1A—L1CAM interactions—SCN2A—migraine	0.000127	0.00449	CbGpPWpGaD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000127	0.00449	CbGpPWpGaD
Zonisamide—CA11—nervous system—migraine	0.000123	0.00541	CbGeAlD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—HTR1A—migraine	0.000122	0.00432	CbGpPWpGaD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—TAC1—migraine	0.00012	0.00425	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—SCN2A—migraine	0.00012	0.00425	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—SCN2A—migraine	0.00012	0.00425	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—SCN1A—migraine	0.00012	0.00425	CbGpPWpGaD
Zonisamide—CA11—central nervous system—migraine	0.000119	0.00521	CbGeAlD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000118	0.00417	CbGpPWpGaD
Zonisamide—CA3—cardiovascular system—migraine	0.000117	0.00514	CbGeAlD
Zonisamide—CA11—cerebellum—migraine	0.000116	0.00509	CbGeAlD
Zonisamide—CA13—brain—migraine	0.000112	0.00492	CbGeAlD
Zonisamide—SCN2B—Developmental Biology—MEF2D—migraine	0.00011	0.00388	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—SCN2A—migraine	0.00011	0.00388	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—MEF2D—migraine	0.00011	0.00388	CbGpPWpGaD
Zonisamide—SCN1A—brainstem—migraine	0.00011	0.00482	CbGeAlD
Zonisamide—SCN4B—brain—migraine	0.000109	0.0048	CbGeAlD
Zonisamide—CACNA1I—brain—migraine	0.000107	0.00469	CbGeAlD
Zonisamide—SCN11A—head—migraine	0.000106	0.00465	CbGeAlD
Zonisamide—SCN5A—L1CAM interactions—SCN1A—migraine	0.000105	0.00372	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—SCN2A—migraine	0.000102	0.00361	CbGpPWpGaD
Zonisamide—CACNA1G—head—migraine	0.000101	0.00444	CbGeAlD
Zonisamide—SCN2A—brainstem—migraine	0.000101	0.00443	CbGeAlD
Zonisamide—SCN4B—Developmental Biology—MEF2D—migraine	0.000101	0.00355	CbGpPWpGaD
Zonisamide—SCN11A—nervous system—migraine	0.0001	0.00441	CbGeAlD
Zonisamide—CACNA1H—cardiovascular system—migraine	9.76e-05	0.00429	CbGeAlD
Zonisamide—SCN11A—central nervous system—migraine	9.66e-05	0.00425	CbGeAlD
Zonisamide—CACNA1G—nervous system—migraine	9.57e-05	0.00421	CbGeAlD
Zonisamide—AOX1—trigeminal ganglion—migraine	9.57e-05	0.00421	CbGeAlD
Zonisamide—CA11—brain—migraine	9.41e-05	0.00413	CbGeAlD
Zonisamide—SCN3B—Developmental Biology—MEF2D—migraine	9.35e-05	0.0033	CbGpPWpGaD
Zonisamide—CACNA1G—central nervous system—migraine	9.22e-05	0.00405	CbGeAlD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—BDNF—migraine	9.22e-05	0.00326	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—SCN1A—migraine	9.1e-05	0.00321	CbGpPWpGaD
Zonisamide—CACNA1G—cerebellum—migraine	9.01e-05	0.00396	CbGeAlD
Zonisamide—SCN5A—L1CAM interactions—SCN2A—migraine	8.94e-05	0.00316	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—SCN1A—migraine	8.62e-05	0.00305	CbGpPWpGaD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—BDNF—migraine	8.57e-05	0.00303	CbGpPWpGaD
Zonisamide—CA6—head—migraine	8.37e-05	0.00368	CbGeAlD
Zonisamide—CA4—neck—migraine	8.23e-05	0.00361	CbGeAlD
Zonisamide—CA3—head—migraine	7.92e-05	0.00348	CbGeAlD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—HTR2A—migraine	7.79e-05	0.00275	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—SCN2A—migraine	7.73e-05	0.00273	CbGpPWpGaD
Zonisamide—CA7—cerebellum—migraine	7.71e-05	0.00339	CbGeAlD
Zonisamide—SCN11A—brain—migraine	7.67e-05	0.00337	CbGeAlD
Zonisamide—CA3—nervous system—migraine	7.51e-05	0.0033	CbGeAlD
Zonisamide—CA5B—cardiovascular system—migraine	7.43e-05	0.00327	CbGeAlD
Zonisamide—MAOB—trigeminal ganglion—migraine	7.38e-05	0.00324	CbGeAlD
Zonisamide—SCN11A—Axon guidance—SCN2A—migraine	7.33e-05	0.00259	CbGpPWpGaD
Zonisamide—CACNA1G—brain—migraine	7.32e-05	0.00322	CbGeAlD
Zonisamide—MAOA—neck—migraine	7.29e-05	0.0032	CbGeAlD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—HTR2A—migraine	7.24e-05	0.00256	CbGpPWpGaD
Zonisamide—CA3—central nervous system—migraine	7.23e-05	0.00318	CbGeAlD
Zonisamide—SCN5A—cardiovascular system—migraine	7.2e-05	0.00316	CbGeAlD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—ATP1A3—migraine	7.13e-05	0.00252	CbGpPWpGaD
Zonisamide—CA2—neck—migraine	6.82e-05	0.003	CbGeAlD
Zonisamide—CA9—cerebellum—migraine	6.77e-05	0.00297	CbGeAlD
Zonisamide—CACNA1G—Axon guidance—SCN1A—migraine	6.71e-05	0.00237	CbGpPWpGaD
Zonisamide—CA1—cardiovascular system—migraine	6.56e-05	0.00288	CbGeAlD
Zonisamide—MAOB—brainstem—migraine	6.53e-05	0.00287	CbGeAlD
Zonisamide—CACNA1H—Axon guidance—SCN1A—migraine	6.5e-05	0.00229	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—SCN1A—migraine	6.49e-05	0.00229	CbGpPWpGaD
Zonisamide—CA14—cerebellum—migraine	6.42e-05	0.00282	CbGeAlD
Zonisamide—SCN9A—Axon guidance—SCN1A—migraine	6.38e-05	0.00225	CbGpPWpGaD
Zonisamide—MAOA—trigeminal ganglion—migraine	6.29e-05	0.00276	CbGeAlD
Zonisamide—SCN4A—head—migraine	6.29e-05	0.00276	CbGeAlD
Zonisamide—CA4—brainstem—migraine	6.29e-05	0.00276	CbGeAlD
Zonisamide—CACNA1H—nervous system—migraine	6.26e-05	0.00275	CbGeAlD
Zonisamide—CA7—brain—migraine	6.26e-05	0.00275	CbGeAlD
Zonisamide—SCN11A—Developmental Biology—SCN1A—migraine	6.15e-05	0.00217	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—SCN1A—migraine	6.1e-05	0.00216	CbGpPWpGaD
Zonisamide—SCN1A—head—migraine	6.06e-05	0.00266	CbGeAlD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—HTR3A—migraine	6.06e-05	0.00214	CbGpPWpGaD
Zonisamide—SCN4A—nervous system—migraine	5.96e-05	0.00262	CbGeAlD
Zonisamide—CACNA1H—cerebellum—migraine	5.89e-05	0.00259	CbGeAlD
Zonisamide—CA2—trigeminal ganglion—migraine	5.89e-05	0.00259	CbGeAlD
Zonisamide—SCN2A—Axon guidance—SCN1A—migraine	5.86e-05	0.00207	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—SCN1A—migraine	5.86e-05	0.00207	CbGpPWpGaD
Zonisamide—SCN1A—nervous system—migraine	5.75e-05	0.00253	CbGeAlD
Zonisamide—CA3—brain—migraine	5.74e-05	0.00252	CbGeAlD
Zonisamide—SCN4A—central nervous system—migraine	5.74e-05	0.00252	CbGeAlD
Zonisamide—CACNA1G—Axon guidance—SCN2A—migraine	5.7e-05	0.00201	CbGpPWpGaD
Zonisamide—CA12—head—migraine	5.61e-05	0.00247	CbGeAlD
Zonisamide—MAOA—brainstem—migraine	5.57e-05	0.00245	CbGeAlD
Zonisamide—SCN2A—head—migraine	5.57e-05	0.00245	CbGeAlD
Zonisamide—SCN1A—central nervous system—migraine	5.54e-05	0.00243	CbGeAlD
Zonisamide—CACNA1H—Axon guidance—SCN2A—migraine	5.52e-05	0.00195	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—SCN2A—migraine	5.52e-05	0.00195	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—SCN2A—migraine	5.42e-05	0.00192	CbGpPWpGaD
Zonisamide—SCN1A—cerebellum—migraine	5.41e-05	0.00238	CbGeAlD
Zonisamide—CA13—Metabolism—CACNA1A—migraine	5.36e-05	0.0019	CbGpPWpGaD
Zonisamide—MAOB—cardiovascular system—migraine	5.33e-05	0.00234	CbGeAlD
Zonisamide—CA12—nervous system—migraine	5.32e-05	0.00234	CbGeAlD
Zonisamide—SCN2A—nervous system—migraine	5.28e-05	0.00232	CbGeAlD
Zonisamide—SCN11A—Developmental Biology—SCN2A—migraine	5.23e-05	0.00185	CbGpPWpGaD
Zonisamide—CA14—brain—migraine	5.21e-05	0.00229	CbGeAlD
Zonisamide—CA2—brainstem—migraine	5.21e-05	0.00229	CbGeAlD
Zonisamide—SCN3A—Axon guidance—SCN2A—migraine	5.19e-05	0.00183	CbGpPWpGaD
Zonisamide—CA4—cardiovascular system—migraine	5.13e-05	0.00225	CbGeAlD
Zonisamide—CA12—central nervous system—migraine	5.12e-05	0.00225	CbGeAlD
Zonisamide—SCN9A—brain—migraine	5.11e-05	0.00224	CbGeAlD
Zonisamide—MAOA—SIDS Susceptibility Pathways—ATP1A3—migraine	5.1e-05	0.0018	CbGpPWpGaD
Zonisamide—SCN2A—central nervous system—migraine	5.08e-05	0.00223	CbGeAlD
Zonisamide—CACNA1I—Developmental Biology—MEF2D—migraine	5.05e-05	0.00178	CbGpPWpGaD
Zonisamide—CA5B—head—migraine	5.03e-05	0.00221	CbGeAlD
Zonisamide—SCN4A—Axon guidance—SCN2A—migraine	4.98e-05	0.00176	CbGpPWpGaD
Zonisamide—SCN2A—cerebellum—migraine	4.97e-05	0.00218	CbGeAlD
Zonisamide—SCN3A—head—migraine	4.89e-05	0.00215	CbGeAlD
Zonisamide—SCN5A—head—migraine	4.88e-05	0.00214	CbGeAlD
Zonisamide—SCN1A—Axon guidance—SCN2A—migraine	4.81e-05	0.0017	CbGpPWpGaD
Zonisamide—CACNA1H—brain—migraine	4.79e-05	0.0021	CbGeAlD
Zonisamide—CACNA1G—Developmental Biology—SCN1A—migraine	4.79e-05	0.00169	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—MEF2D—migraine	4.79e-05	0.00169	CbGpPWpGaD
Zonisamide—CA5B—nervous system—migraine	4.77e-05	0.0021	CbGeAlD
Zonisamide—MAOA—Neuronal System—KCNK18—migraine	4.74e-05	0.00168	CbGpPWpGaD
Zonisamide—SCN3A—nervous system—migraine	4.64e-05	0.00204	CbGeAlD
Zonisamide—CACNA1H—Developmental Biology—SCN1A—migraine	4.63e-05	0.00164	CbGpPWpGaD
Zonisamide—SCN5A—nervous system—migraine	4.62e-05	0.00203	CbGeAlD
Zonisamide—CA5B—central nervous system—migraine	4.59e-05	0.00202	CbGeAlD
Zonisamide—SCN4A—brain—migraine	4.56e-05	0.002	CbGeAlD
Zonisamide—SCN9A—Developmental Biology—SCN1A—migraine	4.55e-05	0.00161	CbGpPWpGaD
Zonisamide—MAOA—cardiovascular system—migraine	4.55e-05	0.002	CbGeAlD
Zonisamide—SCN3A—central nervous system—migraine	4.47e-05	0.00196	CbGeAlD
Zonisamide—SCN5A—central nervous system—migraine	4.45e-05	0.00196	CbGeAlD
Zonisamide—CA1—head—migraine	4.45e-05	0.00195	CbGeAlD
Zonisamide—SCN1A—brain—migraine	4.39e-05	0.00193	CbGeAlD
Zonisamide—SCN3A—cerebellum—migraine	4.36e-05	0.00192	CbGeAlD
Zonisamide—SCN3A—Developmental Biology—SCN1A—migraine	4.35e-05	0.00154	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—HTR3A—migraine	4.34e-05	0.00153	CbGpPWpGaD
Zonisamide—CA2—cardiovascular system—migraine	4.25e-05	0.00187	CbGeAlD
Zonisamide—CA1—nervous system—migraine	4.21e-05	0.00185	CbGeAlD
Zonisamide—SCN2A—Developmental Biology—SCN1A—migraine	4.18e-05	0.00148	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—SCN1A—migraine	4.18e-05	0.00148	CbGpPWpGaD
Zonisamide—AOX1—cerebellum—migraine	4.18e-05	0.00184	CbGeAlD
Zonisamide—CACNA1G—Developmental Biology—SCN2A—migraine	4.07e-05	0.00144	CbGpPWpGaD
Zonisamide—CA12—brain—migraine	4.07e-05	0.00179	CbGeAlD
Zonisamide—CA1—central nervous system—migraine	4.06e-05	0.00178	CbGeAlD
Zonisamide—SCN2A—brain—migraine	4.03e-05	0.00177	CbGeAlD
Zonisamide—SCN5A—Axon guidance—SCN1A—migraine	3.97e-05	0.0014	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—SCN2A—migraine	3.94e-05	0.00139	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—SCN2A—migraine	3.87e-05	0.00137	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—MEF2D—migraine	3.72e-05	0.00131	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—SCN2A—migraine	3.7e-05	0.00131	CbGpPWpGaD
Zonisamide—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	3.67e-05	0.0013	CbGpPWpGaD
Zonisamide—MAOA—Oxidative Stress—FOS—migraine	3.65e-05	0.00129	CbGpPWpGaD
Zonisamide—CA5B—brain—migraine	3.65e-05	0.0016	CbGeAlD
Zonisamide—MAOB—head—migraine	3.61e-05	0.00158	CbGeAlD
Zonisamide—CACNA1H—Developmental Biology—MEF2D—migraine	3.6e-05	0.00127	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—SCN2A—migraine	3.56e-05	0.00126	CbGpPWpGaD
Zonisamide—SCN3A—brain—migraine	3.55e-05	0.00156	CbGeAlD
Zonisamide—SCN9A—Developmental Biology—MEF2D—migraine	3.54e-05	0.00125	CbGpPWpGaD
Zonisamide—SCN5A—brain—migraine	3.53e-05	0.00155	CbGeAlD
Zonisamide—CA4—head—migraine	3.47e-05	0.00153	CbGeAlD
Zonisamide—SCN1A—Developmental Biology—SCN2A—migraine	3.43e-05	0.00121	CbGpPWpGaD
Zonisamide—MAOB—nervous system—migraine	3.42e-05	0.0015	CbGeAlD
Zonisamide—CACNA1H—Corticotropin-releasing hormone—FOS—migraine	3.41e-05	0.0012	CbGpPWpGaD
Zonisamide—AOX1—brain—migraine	3.39e-05	0.00149	CbGeAlD
Zonisamide—SCN3A—Developmental Biology—MEF2D—migraine	3.39e-05	0.0012	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—SCN2A—migraine	3.38e-05	0.00119	CbGpPWpGaD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—TNF—migraine	3.35e-05	0.00118	CbGpPWpGaD
Zonisamide—CA4—nervous system—migraine	3.29e-05	0.00145	CbGeAlD
Zonisamide—MAOB—central nervous system—migraine	3.29e-05	0.00145	CbGeAlD
Zonisamide—CA9—HIF-1-alpha transcription factor network—FOS—migraine	3.29e-05	0.00116	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MEF2D—migraine	3.25e-05	0.00115	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MEF2D—migraine	3.25e-05	0.00115	CbGpPWpGaD
Zonisamide—CA1—brain—migraine	3.22e-05	0.00142	CbGeAlD
Zonisamide—MAOB—cerebellum—migraine	3.22e-05	0.00141	CbGeAlD
Zonisamide—CA4—central nervous system—migraine	3.17e-05	0.00139	CbGeAlD
Zonisamide—SCN1A—Developmental Biology—MEF2D—migraine	3.14e-05	0.00111	CbGpPWpGaD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—TNF—migraine	3.11e-05	0.0011	CbGpPWpGaD
Zonisamide—CA4—cerebellum—migraine	3.1e-05	0.00136	CbGeAlD
Zonisamide—MAOA—head—migraine	3.08e-05	0.00135	CbGeAlD
Zonisamide—MAOA—Transmission across Chemical Synapses—CACNA1A—migraine	3.02e-05	0.00107	CbGpPWpGaD
Zonisamide—MAOA—nervous system—migraine	2.92e-05	0.00128	CbGeAlD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—HTR1A—migraine	2.88e-05	0.00102	CbGpPWpGaD
Zonisamide—CA2—head—migraine	2.88e-05	0.00127	CbGeAlD
Zonisamide—Hypertension—Valproic Acid—migraine	2.84e-05	0.000645	CcSEcCtD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—TAC1—migraine	2.84e-05	0.001	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—SCN1A—migraine	2.84e-05	0.001	CbGpPWpGaD
Zonisamide—Immune system disorder—Gabapentin—migraine	2.83e-05	0.000643	CcSEcCtD
Zonisamide—Mediastinal disorder—Gabapentin—migraine	2.82e-05	0.000641	CcSEcCtD
Zonisamide—CA3—Metabolism—CACNA1A—migraine	2.82e-05	0.000996	CbGpPWpGaD
Zonisamide—Diarrhoea—Propranolol—migraine	2.82e-05	0.00064	CcSEcCtD
Zonisamide—MAOA—central nervous system—migraine	2.81e-05	0.00123	CbGeAlD
Zonisamide—Chest pain—Valproic Acid—migraine	2.8e-05	0.000636	CcSEcCtD
Zonisamide—Myalgia—Valproic Acid—migraine	2.8e-05	0.000636	CcSEcCtD
Zonisamide—Arthralgia—Valproic Acid—migraine	2.8e-05	0.000636	CcSEcCtD
Zonisamide—Haematuria—Topiramate—migraine	2.8e-05	0.000636	CcSEcCtD
Zonisamide—Anxiety—Valproic Acid—migraine	2.79e-05	0.000634	CcSEcCtD
Zonisamide—Hypersensitivity—Verapamil—migraine	2.79e-05	0.000634	CcSEcCtD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—SLC6A4—migraine	2.78e-05	0.000984	CbGpPWpGaD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	2.78e-05	0.000632	CcSEcCtD
Zonisamide—Alopecia—Gabapentin—migraine	2.77e-05	0.000629	CcSEcCtD
Zonisamide—Discomfort—Valproic Acid—migraine	2.77e-05	0.000628	CcSEcCtD
Zonisamide—MAOA—cerebellum—migraine	2.75e-05	0.00121	CbGeAlD
Zonisamide—Mental disorder—Gabapentin—migraine	2.74e-05	0.000623	CcSEcCtD
Zonisamide—Agranulocytosis—Topiramate—migraine	2.74e-05	0.000622	CcSEcCtD
Zonisamide—Dry mouth—Valproic Acid—migraine	2.74e-05	0.000622	CcSEcCtD
Zonisamide—CA2—nervous system—migraine	2.73e-05	0.0012	CbGeAlD
Zonisamide—Malnutrition—Gabapentin—migraine	2.73e-05	0.000619	CcSEcCtD
Zonisamide—Dizziness—Propranolol—migraine	2.72e-05	0.000618	CcSEcCtD
Zonisamide—Asthenia—Verapamil—migraine	2.72e-05	0.000617	CcSEcCtD
Zonisamide—Confusional state—Valproic Acid—migraine	2.71e-05	0.000615	CcSEcCtD
Zonisamide—Flatulence—Gabapentin—migraine	2.69e-05	0.00061	CcSEcCtD
Zonisamide—Oedema—Valproic Acid—migraine	2.68e-05	0.00061	CcSEcCtD
Zonisamide—Bradycardia—Topiramate—migraine	2.68e-05	0.000609	CcSEcCtD
Zonisamide—Pruritus—Verapamil—migraine	2.68e-05	0.000608	CcSEcCtD
Zonisamide—Tension—Gabapentin—migraine	2.68e-05	0.000608	CcSEcCtD
Zonisamide—Dysgeusia—Gabapentin—migraine	2.67e-05	0.000606	CcSEcCtD
Zonisamide—Infection—Valproic Acid—migraine	2.67e-05	0.000606	CcSEcCtD
Zonisamide—Nervousness—Gabapentin—migraine	2.65e-05	0.000602	CcSEcCtD
Zonisamide—Rhinitis—Topiramate—migraine	2.64e-05	0.0006	CcSEcCtD
Zonisamide—Nervous system disorder—Valproic Acid—migraine	2.63e-05	0.000598	CcSEcCtD
Zonisamide—Vertigo—Timolol—migraine	2.63e-05	0.000598	CcSEcCtD
Zonisamide—CA2—central nervous system—migraine	2.63e-05	0.00116	CbGeAlD
Zonisamide—Thrombocytopenia—Valproic Acid—migraine	2.63e-05	0.000597	CcSEcCtD
Zonisamide—Syncope—Timolol—migraine	2.63e-05	0.000596	CcSEcCtD
Zonisamide—Hallucination—Topiramate—migraine	2.62e-05	0.000596	CcSEcCtD
Zonisamide—Muscle spasms—Gabapentin—migraine	2.62e-05	0.000595	CcSEcCtD
Zonisamide—Tachycardia—Valproic Acid—migraine	2.62e-05	0.000595	CcSEcCtD
Zonisamide—Vomiting—Propranolol—migraine	2.62e-05	0.000594	CcSEcCtD
Zonisamide—Pharyngitis—Topiramate—migraine	2.62e-05	0.000594	CcSEcCtD
Zonisamide—MAOB—brain—migraine	2.61e-05	0.00115	CbGeAlD
Zonisamide—Skin disorder—Valproic Acid—migraine	2.61e-05	0.000592	CcSEcCtD
Zonisamide—Urinary tract disorder—Topiramate—migraine	2.6e-05	0.000591	CcSEcCtD
Zonisamide—Oedema peripheral—Topiramate—migraine	2.6e-05	0.00059	CcSEcCtD
Zonisamide—Hyperhidrosis—Valproic Acid—migraine	2.6e-05	0.000589	CcSEcCtD
Zonisamide—Rash—Propranolol—migraine	2.6e-05	0.000589	CcSEcCtD
Zonisamide—Dermatitis—Propranolol—migraine	2.59e-05	0.000589	CcSEcCtD
Zonisamide—Diarrhoea—Verapamil—migraine	2.59e-05	0.000588	CcSEcCtD
Zonisamide—Connective tissue disorder—Topiramate—migraine	2.59e-05	0.000588	CcSEcCtD
Zonisamide—Palpitations—Timolol—migraine	2.59e-05	0.000588	CcSEcCtD
Zonisamide—Urethral disorder—Topiramate—migraine	2.58e-05	0.000587	CcSEcCtD
Zonisamide—Loss of consciousness—Timolol—migraine	2.57e-05	0.000585	CcSEcCtD
Zonisamide—CA2—cerebellum—migraine	2.57e-05	0.00113	CbGeAlD
Zonisamide—Anorexia—Valproic Acid—migraine	2.56e-05	0.000581	CcSEcCtD
Zonisamide—Cough—Timolol—migraine	2.56e-05	0.00058	CcSEcCtD
Zonisamide—Tremor—Gabapentin—migraine	2.56e-05	0.00058	CcSEcCtD
Zonisamide—Ill-defined disorder—Gabapentin—migraine	2.53e-05	0.000575	CcSEcCtD
Zonisamide—Hypertension—Timolol—migraine	2.53e-05	0.000574	CcSEcCtD
Zonisamide—Anaemia—Gabapentin—migraine	2.52e-05	0.000572	CcSEcCtD
Zonisamide—CA4—brain—migraine	2.52e-05	0.00111	CbGeAlD
Zonisamide—Hypotension—Valproic Acid—migraine	2.51e-05	0.00057	CcSEcCtD
Zonisamide—Agitation—Gabapentin—migraine	2.51e-05	0.000569	CcSEcCtD
Zonisamide—Dizziness—Verapamil—migraine	2.5e-05	0.000569	CcSEcCtD
Zonisamide—Myalgia—Timolol—migraine	2.49e-05	0.000566	CcSEcCtD
Zonisamide—Chest pain—Timolol—migraine	2.49e-05	0.000566	CcSEcCtD
Zonisamide—Arthralgia—Timolol—migraine	2.49e-05	0.000566	CcSEcCtD
Zonisamide—Erythema multiforme—Topiramate—migraine	2.49e-05	0.000566	CcSEcCtD
Zonisamide—Anxiety—Timolol—migraine	2.48e-05	0.000564	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	2.48e-05	0.000562	CcSEcCtD
Zonisamide—Discomfort—Timolol—migraine	2.46e-05	0.000559	CcSEcCtD
Zonisamide—Eye disorder—Topiramate—migraine	2.46e-05	0.000559	CcSEcCtD
Zonisamide—Malaise—Gabapentin—migraine	2.46e-05	0.000559	CcSEcCtD
Zonisamide—Tinnitus—Topiramate—migraine	2.46e-05	0.000558	CcSEcCtD
Zonisamide—Vertigo—Gabapentin—migraine	2.45e-05	0.000556	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Valproic Acid—migraine	2.45e-05	0.000556	CcSEcCtD
Zonisamide—Syncope—Gabapentin—migraine	2.45e-05	0.000555	CcSEcCtD
Zonisamide—Nausea—Propranolol—migraine	2.45e-05	0.000555	CcSEcCtD
Zonisamide—Leukopenia—Gabapentin—migraine	2.44e-05	0.000554	CcSEcCtD
Zonisamide—Dry mouth—Timolol—migraine	2.44e-05	0.000554	CcSEcCtD
Zonisamide—Insomnia—Valproic Acid—migraine	2.43e-05	0.000551	CcSEcCtD
Zonisamide—SCN5A—Developmental Biology—SCN2A—migraine	2.41e-05	0.000852	CbGpPWpGaD
Zonisamide—Paraesthesia—Valproic Acid—migraine	2.41e-05	0.000547	CcSEcCtD
Zonisamide—Palpitations—Gabapentin—migraine	2.41e-05	0.000547	CcSEcCtD
Zonisamide—Confusional state—Timolol—migraine	2.41e-05	0.000547	CcSEcCtD
Zonisamide—Vomiting—Verapamil—migraine	2.41e-05	0.000547	CcSEcCtD
Zonisamide—Loss of consciousness—Gabapentin—migraine	2.4e-05	0.000544	CcSEcCtD
Zonisamide—Dyspnoea—Valproic Acid—migraine	2.39e-05	0.000544	CcSEcCtD
Zonisamide—Oedema—Timolol—migraine	2.39e-05	0.000543	CcSEcCtD
Zonisamide—Rash—Verapamil—migraine	2.39e-05	0.000542	CcSEcCtD
Zonisamide—Somnolence—Valproic Acid—migraine	2.39e-05	0.000542	CcSEcCtD
Zonisamide—Dermatitis—Verapamil—migraine	2.39e-05	0.000542	CcSEcCtD
Zonisamide—Immune system disorder—Topiramate—migraine	2.38e-05	0.000541	CcSEcCtD
Zonisamide—Cough—Gabapentin—migraine	2.38e-05	0.00054	CcSEcCtD
Zonisamide—Mediastinal disorder—Topiramate—migraine	2.38e-05	0.000539	CcSEcCtD
Zonisamide—Infection—Timolol—migraine	2.37e-05	0.000539	CcSEcCtD
Zonisamide—Headache—Verapamil—migraine	2.37e-05	0.000539	CcSEcCtD
Zonisamide—Dyspepsia—Valproic Acid—migraine	2.36e-05	0.000537	CcSEcCtD
Zonisamide—Convulsion—Gabapentin—migraine	2.36e-05	0.000537	CcSEcCtD
Zonisamide—Hypertension—Gabapentin—migraine	2.35e-05	0.000535	CcSEcCtD
Zonisamide—Shock—Timolol—migraine	2.35e-05	0.000534	CcSEcCtD
Zonisamide—Nervous system disorder—Timolol—migraine	2.34e-05	0.000532	CcSEcCtD
Zonisamide—Decreased appetite—Valproic Acid—migraine	2.33e-05	0.00053	CcSEcCtD
Zonisamide—Alopecia—Topiramate—migraine	2.33e-05	0.000529	CcSEcCtD
Zonisamide—Chest pain—Gabapentin—migraine	2.32e-05	0.000527	CcSEcCtD
Zonisamide—Arthralgia—Gabapentin—migraine	2.32e-05	0.000527	CcSEcCtD
Zonisamide—Myalgia—Gabapentin—migraine	2.32e-05	0.000527	CcSEcCtD
Zonisamide—Skin disorder—Timolol—migraine	2.32e-05	0.000527	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Valproic Acid—migraine	2.32e-05	0.000526	CcSEcCtD
Zonisamide—MAOA—Neuronal System—CACNA1A—migraine	2.32e-05	0.000818	CbGpPWpGaD
Zonisamide—Fatigue—Valproic Acid—migraine	2.31e-05	0.000526	CcSEcCtD
Zonisamide—Anxiety—Gabapentin—migraine	2.31e-05	0.000525	CcSEcCtD
Zonisamide—Hyperhidrosis—Timolol—migraine	2.31e-05	0.000525	CcSEcCtD
Zonisamide—Mental disorder—Topiramate—migraine	2.31e-05	0.000524	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	2.31e-05	0.000524	CcSEcCtD
Zonisamide—Constipation—Valproic Acid—migraine	2.3e-05	0.000521	CcSEcCtD
Zonisamide—Malnutrition—Topiramate—migraine	2.29e-05	0.000521	CcSEcCtD
Zonisamide—Discomfort—Gabapentin—migraine	2.29e-05	0.000521	CcSEcCtD
Zonisamide—Anorexia—Timolol—migraine	2.28e-05	0.000517	CcSEcCtD
Zonisamide—Dry mouth—Gabapentin—migraine	2.27e-05	0.000516	CcSEcCtD
Zonisamide—Flatulence—Topiramate—migraine	2.26e-05	0.000513	CcSEcCtD
Zonisamide—Tension—Topiramate—migraine	2.25e-05	0.000511	CcSEcCtD
Zonisamide—Nausea—Verapamil—migraine	2.25e-05	0.000511	CcSEcCtD
Zonisamide—Dysgeusia—Topiramate—migraine	2.25e-05	0.00051	CcSEcCtD
Zonisamide—Confusional state—Gabapentin—migraine	2.24e-05	0.00051	CcSEcCtD
Zonisamide—Hypotension—Timolol—migraine	2.23e-05	0.000507	CcSEcCtD
Zonisamide—MAOA—brain—migraine	2.23e-05	0.00098	CbGeAlD
Zonisamide—Nervousness—Topiramate—migraine	2.23e-05	0.000506	CcSEcCtD
Zonisamide—Oedema—Gabapentin—migraine	2.23e-05	0.000505	CcSEcCtD
Zonisamide—Feeling abnormal—Valproic Acid—migraine	2.21e-05	0.000502	CcSEcCtD
Zonisamide—Infection—Gabapentin—migraine	2.21e-05	0.000502	CcSEcCtD
Zonisamide—Muscle spasms—Topiramate—migraine	2.21e-05	0.000501	CcSEcCtD
Zonisamide—SCN5A—Developmental Biology—MEF2D—migraine	2.21e-05	0.000779	CbGpPWpGaD
Zonisamide—Gastrointestinal pain—Valproic Acid—migraine	2.2e-05	0.000499	CcSEcCtD
Zonisamide—Shock—Gabapentin—migraine	2.19e-05	0.000497	CcSEcCtD
Zonisamide—Nervous system disorder—Gabapentin—migraine	2.18e-05	0.000496	CcSEcCtD
Zonisamide—Thrombocytopenia—Gabapentin—migraine	2.18e-05	0.000495	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Timolol—migraine	2.18e-05	0.000495	CcSEcCtD
Zonisamide—Tachycardia—Gabapentin—migraine	2.17e-05	0.000493	CcSEcCtD
Zonisamide—Skin disorder—Gabapentin—migraine	2.16e-05	0.000491	CcSEcCtD
Zonisamide—Insomnia—Timolol—migraine	2.16e-05	0.000491	CcSEcCtD
Zonisamide—Hyperhidrosis—Gabapentin—migraine	2.15e-05	0.000489	CcSEcCtD
Zonisamide—Tremor—Topiramate—migraine	2.15e-05	0.000488	CcSEcCtD
Zonisamide—Paraesthesia—Timolol—migraine	2.15e-05	0.000487	CcSEcCtD
Zonisamide—Urticaria—Valproic Acid—migraine	2.13e-05	0.000484	CcSEcCtD
Zonisamide—Dyspnoea—Timolol—migraine	2.13e-05	0.000484	CcSEcCtD
Zonisamide—Ill-defined disorder—Topiramate—migraine	2.13e-05	0.000483	CcSEcCtD
Zonisamide—Somnolence—Timolol—migraine	2.12e-05	0.000483	CcSEcCtD
Zonisamide—Abdominal pain—Valproic Acid—migraine	2.12e-05	0.000482	CcSEcCtD
Zonisamide—Body temperature increased—Valproic Acid—migraine	2.12e-05	0.000482	CcSEcCtD
Zonisamide—Anorexia—Gabapentin—migraine	2.12e-05	0.000482	CcSEcCtD
Zonisamide—Anaemia—Topiramate—migraine	2.12e-05	0.000482	CcSEcCtD
Zonisamide—Agitation—Topiramate—migraine	2.11e-05	0.000479	CcSEcCtD
Zonisamide—Dyspepsia—Timolol—migraine	2.1e-05	0.000478	CcSEcCtD
Zonisamide—CA2—brain—migraine	2.09e-05	0.000917	CbGeAlD
Zonisamide—Hypotension—Gabapentin—migraine	2.08e-05	0.000472	CcSEcCtD
Zonisamide—Decreased appetite—Timolol—migraine	2.08e-05	0.000472	CcSEcCtD
Zonisamide—Malaise—Topiramate—migraine	2.07e-05	0.00047	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Timolol—migraine	2.06e-05	0.000469	CcSEcCtD
Zonisamide—MAOA—SIDS Susceptibility Pathways—HTR1A—migraine	2.06e-05	0.000729	CbGpPWpGaD
Zonisamide—Vertigo—Topiramate—migraine	2.06e-05	0.000468	CcSEcCtD
Zonisamide—Fatigue—Timolol—migraine	2.06e-05	0.000468	CcSEcCtD
Zonisamide—Syncope—Topiramate—migraine	2.06e-05	0.000467	CcSEcCtD
Zonisamide—Leukopenia—Topiramate—migraine	2.05e-05	0.000466	CcSEcCtD
Zonisamide—MAOA—SIDS Susceptibility Pathways—TAC1—migraine	2.03e-05	0.000717	CbGpPWpGaD
Zonisamide—Musculoskeletal discomfort—Gabapentin—migraine	2.03e-05	0.000461	CcSEcCtD
Zonisamide—Palpitations—Topiramate—migraine	2.03e-05	0.00046	CcSEcCtD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—BDNF—migraine	2.02e-05	0.000714	CbGpPWpGaD
Zonisamide—Loss of consciousness—Topiramate—migraine	2.02e-05	0.000458	CcSEcCtD
Zonisamide—Insomnia—Gabapentin—migraine	2.01e-05	0.000457	CcSEcCtD
Zonisamide—Cough—Topiramate—migraine	2e-05	0.000455	CcSEcCtD
Zonisamide—Paraesthesia—Gabapentin—migraine	2e-05	0.000454	CcSEcCtD
Zonisamide—MAOA—SIDS Susceptibility Pathways—SLC6A4—migraine	1.99e-05	0.000704	CbGpPWpGaD
Zonisamide—Convulsion—Topiramate—migraine	1.99e-05	0.000451	CcSEcCtD
Zonisamide—Dyspnoea—Gabapentin—migraine	1.98e-05	0.000451	CcSEcCtD
Zonisamide—Hypertension—Topiramate—migraine	1.98e-05	0.00045	CcSEcCtD
Zonisamide—Somnolence—Gabapentin—migraine	1.98e-05	0.000449	CcSEcCtD
Zonisamide—Hypersensitivity—Valproic Acid—migraine	1.98e-05	0.000449	CcSEcCtD
Zonisamide—Feeling abnormal—Timolol—migraine	1.97e-05	0.000447	CcSEcCtD
Zonisamide—Dyspepsia—Gabapentin—migraine	1.96e-05	0.000445	CcSEcCtD
Zonisamide—Gastrointestinal pain—Timolol—migraine	1.95e-05	0.000444	CcSEcCtD
Zonisamide—Myalgia—Topiramate—migraine	1.95e-05	0.000444	CcSEcCtD
Zonisamide—Arthralgia—Topiramate—migraine	1.95e-05	0.000444	CcSEcCtD
Zonisamide—Chest pain—Topiramate—migraine	1.95e-05	0.000444	CcSEcCtD
Zonisamide—Anxiety—Topiramate—migraine	1.95e-05	0.000442	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	1.94e-05	0.000441	CcSEcCtD
Zonisamide—Decreased appetite—Gabapentin—migraine	1.93e-05	0.000439	CcSEcCtD
Zonisamide—Discomfort—Topiramate—migraine	1.93e-05	0.000438	CcSEcCtD
Zonisamide—Asthenia—Valproic Acid—migraine	1.93e-05	0.000437	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Gabapentin—migraine	1.92e-05	0.000436	CcSEcCtD
Zonisamide—Fatigue—Gabapentin—migraine	1.92e-05	0.000436	CcSEcCtD
Zonisamide—Dry mouth—Topiramate—migraine	1.91e-05	0.000434	CcSEcCtD
Zonisamide—Constipation—Gabapentin—migraine	1.9e-05	0.000432	CcSEcCtD
Zonisamide—Pruritus—Valproic Acid—migraine	1.9e-05	0.000431	CcSEcCtD
Zonisamide—Urticaria—Timolol—migraine	1.9e-05	0.000431	CcSEcCtD
Zonisamide—Body temperature increased—Timolol—migraine	1.89e-05	0.000429	CcSEcCtD
Zonisamide—Abdominal pain—Timolol—migraine	1.89e-05	0.000429	CcSEcCtD
Zonisamide—Confusional state—Topiramate—migraine	1.89e-05	0.000429	CcSEcCtD
Zonisamide—Oedema—Topiramate—migraine	1.87e-05	0.000425	CcSEcCtD
Zonisamide—Infection—Topiramate—migraine	1.86e-05	0.000422	CcSEcCtD
Zonisamide—Shock—Topiramate—migraine	1.84e-05	0.000418	CcSEcCtD
Zonisamide—Diarrhoea—Valproic Acid—migraine	1.84e-05	0.000417	CcSEcCtD
Zonisamide—Nervous system disorder—Topiramate—migraine	1.84e-05	0.000417	CcSEcCtD
Zonisamide—Feeling abnormal—Gabapentin—migraine	1.83e-05	0.000417	CcSEcCtD
Zonisamide—Thrombocytopenia—Topiramate—migraine	1.83e-05	0.000416	CcSEcCtD
Zonisamide—Tachycardia—Topiramate—migraine	1.83e-05	0.000415	CcSEcCtD
Zonisamide—Gastrointestinal pain—Gabapentin—migraine	1.82e-05	0.000413	CcSEcCtD
Zonisamide—Skin disorder—Topiramate—migraine	1.82e-05	0.000413	CcSEcCtD
Zonisamide—CA14—Metabolism—CACNA1A—migraine	1.82e-05	0.000642	CbGpPWpGaD
Zonisamide—Hyperhidrosis—Topiramate—migraine	1.81e-05	0.000411	CcSEcCtD
Zonisamide—Anorexia—Topiramate—migraine	1.78e-05	0.000405	CcSEcCtD
Zonisamide—Dizziness—Valproic Acid—migraine	1.78e-05	0.000403	CcSEcCtD
Zonisamide—CA13—Metabolism—MTHFR—migraine	1.77e-05	0.000627	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—CACNA1A—migraine	1.77e-05	0.000625	CbGpPWpGaD
Zonisamide—CA6—Metabolism—CACNA1A—migraine	1.77e-05	0.000625	CbGpPWpGaD
Zonisamide—Urticaria—Gabapentin—migraine	1.77e-05	0.000402	CcSEcCtD
Zonisamide—CYP3A4—nervous system—migraine	1.76e-05	0.000774	CbGeAlD
Zonisamide—Hypersensitivity—Timolol—migraine	1.76e-05	0.0004	CcSEcCtD
Zonisamide—Abdominal pain—Gabapentin—migraine	1.76e-05	0.0004	CcSEcCtD
Zonisamide—Body temperature increased—Gabapentin—migraine	1.76e-05	0.0004	CcSEcCtD
Zonisamide—Hypotension—Topiramate—migraine	1.75e-05	0.000397	CcSEcCtD
Zonisamide—Asthenia—Timolol—migraine	1.71e-05	0.000389	CcSEcCtD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—HTR2A—migraine	1.71e-05	0.000603	CbGpPWpGaD
Zonisamide—Vomiting—Valproic Acid—migraine	1.71e-05	0.000388	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Topiramate—migraine	1.71e-05	0.000387	CcSEcCtD
Zonisamide—CYP3A4—central nervous system—migraine	1.7e-05	0.000745	CbGeAlD
Zonisamide—Insomnia—Topiramate—migraine	1.69e-05	0.000385	CcSEcCtD
Zonisamide—Rash—Valproic Acid—migraine	1.69e-05	0.000384	CcSEcCtD
Zonisamide—Dermatitis—Valproic Acid—migraine	1.69e-05	0.000384	CcSEcCtD
Zonisamide—Pruritus—Timolol—migraine	1.69e-05	0.000384	CcSEcCtD
Zonisamide—Headache—Valproic Acid—migraine	1.68e-05	0.000382	CcSEcCtD
Zonisamide—Paraesthesia—Topiramate—migraine	1.68e-05	0.000382	CcSEcCtD
Zonisamide—Dyspnoea—Topiramate—migraine	1.67e-05	0.000379	CcSEcCtD
Zonisamide—Somnolence—Topiramate—migraine	1.66e-05	0.000378	CcSEcCtD
Zonisamide—CA7—Metabolism—CACNA1A—migraine	1.65e-05	0.000584	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—CACNA1A—migraine	1.65e-05	0.000584	CbGpPWpGaD
Zonisamide—Dyspepsia—Topiramate—migraine	1.65e-05	0.000374	CcSEcCtD
Zonisamide—Hypersensitivity—Gabapentin—migraine	1.64e-05	0.000372	CcSEcCtD
Zonisamide—Diarrhoea—Timolol—migraine	1.64e-05	0.000371	CcSEcCtD
Zonisamide—Decreased appetite—Topiramate—migraine	1.63e-05	0.00037	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Topiramate—migraine	1.62e-05	0.000367	CcSEcCtD
Zonisamide—Fatigue—Topiramate—migraine	1.61e-05	0.000367	CcSEcCtD
Zonisamide—Constipation—Topiramate—migraine	1.6e-05	0.000364	CcSEcCtD
Zonisamide—Asthenia—Gabapentin—migraine	1.6e-05	0.000363	CcSEcCtD
Zonisamide—Nausea—Valproic Acid—migraine	1.59e-05	0.000362	CcSEcCtD
Zonisamide—Dizziness—Timolol—migraine	1.58e-05	0.000359	CcSEcCtD
Zonisamide—Pruritus—Gabapentin—migraine	1.57e-05	0.000358	CcSEcCtD
Zonisamide—Feeling abnormal—Topiramate—migraine	1.54e-05	0.00035	CcSEcCtD
Zonisamide—Gastrointestinal pain—Topiramate—migraine	1.53e-05	0.000348	CcSEcCtD
Zonisamide—CA12—Metabolism—CACNA1A—migraine	1.53e-05	0.000541	CbGpPWpGaD
Zonisamide—Diarrhoea—Gabapentin—migraine	1.52e-05	0.000346	CcSEcCtD
Zonisamide—Vomiting—Timolol—migraine	1.52e-05	0.000345	CcSEcCtD
Zonisamide—Rash—Timolol—migraine	1.51e-05	0.000342	CcSEcCtD
Zonisamide—Dermatitis—Timolol—migraine	1.51e-05	0.000342	CcSEcCtD
Zonisamide—Headache—Timolol—migraine	1.5e-05	0.00034	CcSEcCtD
Zonisamide—Urticaria—Topiramate—migraine	1.49e-05	0.000338	CcSEcCtD
Zonisamide—Abdominal pain—Topiramate—migraine	1.48e-05	0.000336	CcSEcCtD
Zonisamide—Body temperature increased—Topiramate—migraine	1.48e-05	0.000336	CcSEcCtD
Zonisamide—Dizziness—Gabapentin—migraine	1.47e-05	0.000334	CcSEcCtD
Zonisamide—SCN2B—Developmental Biology—TNF—migraine	1.46e-05	0.000514	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—TNF—migraine	1.46e-05	0.000514	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—BDNF—migraine	1.45e-05	0.000511	CbGpPWpGaD
Zonisamide—Nausea—Timolol—migraine	1.42e-05	0.000322	CcSEcCtD
Zonisamide—Vomiting—Gabapentin—migraine	1.42e-05	0.000321	CcSEcCtD
Zonisamide—Rash—Gabapentin—migraine	1.4e-05	0.000319	CcSEcCtD
Zonisamide—Dermatitis—Gabapentin—migraine	1.4e-05	0.000318	CcSEcCtD
Zonisamide—Headache—Gabapentin—migraine	1.39e-05	0.000317	CcSEcCtD
Zonisamide—Hypersensitivity—Topiramate—migraine	1.38e-05	0.000313	CcSEcCtD
Zonisamide—Asthenia—Topiramate—migraine	1.34e-05	0.000305	CcSEcCtD
Zonisamide—SCN4B—Developmental Biology—TNF—migraine	1.33e-05	0.000471	CbGpPWpGaD
Zonisamide—Pruritus—Topiramate—migraine	1.32e-05	0.000301	CcSEcCtD
Zonisamide—Nausea—Gabapentin—migraine	1.32e-05	0.0003	CcSEcCtD
Zonisamide—Diarrhoea—Topiramate—migraine	1.28e-05	0.000291	CcSEcCtD
Zonisamide—Dizziness—Topiramate—migraine	1.24e-05	0.000281	CcSEcCtD
Zonisamide—SCN3B—Developmental Biology—TNF—migraine	1.24e-05	0.000437	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—HTR2A—migraine	1.22e-05	0.000432	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CACNA1A—migraine	1.22e-05	0.000431	CbGpPWpGaD
Zonisamide—Vomiting—Topiramate—migraine	1.19e-05	0.00027	CcSEcCtD
Zonisamide—Rash—Topiramate—migraine	1.18e-05	0.000268	CcSEcCtD
Zonisamide—Dermatitis—Topiramate—migraine	1.18e-05	0.000268	CcSEcCtD
Zonisamide—Headache—Topiramate—migraine	1.17e-05	0.000266	CcSEcCtD
Zonisamide—CA2—Metabolism—CACNA1A—migraine	1.17e-05	0.000413	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CACNA1A—migraine	1.12e-05	0.000396	CbGpPWpGaD
Zonisamide—Nausea—Topiramate—migraine	1.11e-05	0.000253	CcSEcCtD
Zonisamide—AOX1—Metabolism—CACNA1A—migraine	1.1e-05	0.000389	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—FOS—migraine	1.08e-05	0.000383	CbGpPWpGaD
Zonisamide—AOX1—Disease—LRP1—migraine	1.03e-05	0.000364	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CACNA1A—migraine	9.86e-06	0.000348	CbGpPWpGaD
Zonisamide—CA3—Metabolism—MTHFR—migraine	9.32e-06	0.000329	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CACNA1A—migraine	9.3e-06	0.000328	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—TNF—migraine	7.34e-06	0.000259	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—TNF—migraine	6.69e-06	0.000236	CbGpPWpGaD
Zonisamide—AOX1—Disease—CALCA—migraine	6.64e-06	0.000235	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—TNF—migraine	6.34e-06	0.000224	CbGpPWpGaD
Zonisamide—CA14—Metabolism—MTHFR—migraine	6.01e-06	0.000212	CbGpPWpGaD
Zonisamide—CA6—Metabolism—MTHFR—migraine	5.85e-06	0.000207	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—MTHFR—migraine	5.85e-06	0.000207	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CACNA1A—migraine	5.83e-06	0.000206	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—MTHFR—migraine	5.46e-06	0.000193	CbGpPWpGaD
Zonisamide—CA7—Metabolism—MTHFR—migraine	5.46e-06	0.000193	CbGpPWpGaD
Zonisamide—AOX1—Disease—TGFBR2—migraine	5.35e-06	0.000189	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—TNF—migraine	5.25e-06	0.000186	CbGpPWpGaD
Zonisamide—CA12—Metabolism—MTHFR—migraine	5.06e-06	0.000179	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—TNF—migraine	4.93e-06	0.000174	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—TNF—migraine	4.77e-06	0.000169	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—TNF—migraine	4.69e-06	0.000166	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—TNF—migraine	4.48e-06	0.000158	CbGpPWpGaD
Zonisamide—AOX1—Disease—MTHFR—migraine	4.35e-06	0.000154	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—TNF—migraine	4.31e-06	0.000152	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—TNF—migraine	4.31e-06	0.000152	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—TNF—migraine	4.15e-06	0.000147	CbGpPWpGaD
Zonisamide—CA4—Metabolism—MTHFR—migraine	4.04e-06	0.000143	CbGpPWpGaD
Zonisamide—CA2—Metabolism—MTHFR—migraine	3.87e-06	0.000137	CbGpPWpGaD
Zonisamide—CA1—Metabolism—MTHFR—migraine	3.71e-06	0.000131	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—MTHFR—migraine	3.64e-06	0.000129	CbGpPWpGaD
Zonisamide—CA9—Metabolism—MTHFR—migraine	3.26e-06	0.000115	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—MTHFR—migraine	3.07e-06	0.000109	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—TNF—migraine	2.92e-06	0.000103	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CACNA1A—migraine	2.76e-06	9.76e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—MTHFR—migraine	1.93e-06	6.82e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CACNA1A—migraine	1.66e-06	5.87e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MTHFR—migraine	9.13e-07	3.23e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTHFR—migraine	5.49e-07	1.94e-05	CbGpPWpGaD
